Darentang Unit Xinxin Pharmaceutical Receives Drug Registration Certificate for Saxagliptin-Metformin Tablets
Darentang issued an announcement on August 6 stating that its branch, the Xinxin Pharmaceutical Factory of Tianjin Pharmaceutical Darentang Group Co. , Ltd. , recently received the Drug Registration Certificate for Saxagliptin and Metformin Hydrochloride Extended-Release Tablets (I), approved and issued by the National Medical Products Administration. The drug, used in conjunction with diet and exercise, is indicated for adult patients with type 2 diabetes who are treated with saxagliptin and metformin, to improve glycemic control in these patients.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Pharmaceuticals, with intensity 40/100 and 70% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.